Register today for Lunch & Learn: Leveraging the Central Biorepository to further COVID-19 research
Join the Central Biorepository (CBR) for an upcoming Lunch & Learn on Friday, April 16 from noon – 1 p.m.
During this session, investigators will highlight how they leveraged the services of the CBR over the past year to further research on COVID-19.
During this session, attendees will hear presentations by:
Anna Lok, M.D., assistant dean for clinical research, professor of internal medicine: Lok, along with a team of more than 30 Michigan Medicine staff, quickly came together early on in the pandemic to safely set up a biorepository to collect samples from COVID-positive patients for distribution to researchers. The Biorepository with Special Emphasis on COVID-19, now fully managed by the CBR, currently has an inventory of more than 26,000 samples.
Adam Lauring, M.D., Ph.D., associate professor of microbiology and immunology; associate professor of internal medicine: Lauring worked with the CBR to retrieve aliquots of SARS-CoV-2 test specimens from the Michigan Medicine Clinical Microbiology Laboratory. He and his research team have been able to sequence over 3,700 viruses from individuals across southeast Michigan. Data from this work have provided insight into the epidemiology of SARS-CoV-2 and newer variants, informing public health interventions.
Matthew Cusick, Ph.D., assistant professor of histocompatibility and immunogenetics: Cusick and his team are currently researching the role of major histocompatibility complex immune responses to severe SARS-CoV-2 cases. Looking at factors such as genetics, immune functions, viral pathogenesis and cell distribution of human leukocyte antigen (HLA), Cusick’s team is investigating how HLA is associated with disease severity. Obtaining samples from the CBR has been critical to performing this study and will be incredibly valuable for future COVID-focused studies.
Don’t miss out! Click here to register.